Digital Pathology Services
Advanced Pathology Services for Fast, Reliable Data: Histopathology, IHC, IF, and In Situ Hybridization with Automated Precision
2024-12-05
2024-03-17
At Crown Bioscience, our MuPrime™ Tumor Microarrays (TMAs) are designed to provide researchers with high-quality, homogeneous tumor samples for comprehensive cancer research. These TMAs facilitate high-throughput analysis, essential for biomarker discovery, drug target validation, and translational studies.
For more information or to discuss your research needs, please contact us.
Advanced Pathology Services for Fast, Reliable Data: Histopathology, IHC, IF, and In Situ Hybridization with Automated Precision
Explore the complete transcriptome and over 570 protein targets individually or in tandem, utilizing a range of sample inputs including whole tissue sections, tissue microarrays (TMAs), or organoids.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy